Skip to main content

Ovarian Cancer Clinical Trials

Review the ovarian cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 201-225 of 306

A Cancer Vaccine (NY-ESO-1) and Immunotherapy (Toripalimab) for the Treatment of Stage III/IV Platinum-Refractory or Resistant Ovarian Cancer
Status: Temporarily Closed to Accrual
Location: 2 locations
Targeted CAR-T Cell Therapy (IVS-3001) for the Treatment of Previously Treated Locally Advanced Unresectable or Metastatic HLA-G Positive Solid Tumors
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
FRalphaDC Vaccine with Pembrolizumab for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FRAPPE Trial
Status: Temporarily Closed to Accrual
Location: 3 locations
Indocyanine Green for Imaging of Solid Tumors during Surgery Compared to Standard of Care
Status: Temporarily Closed to Accrual
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Testing the Combination of ZEN003694 and Nivolumab with or without Ipilimumab in Solid Tumors
Status: Temporarily Closed to Accrual
Location: 6 locations
Niraparib and Copanlisib in Treating Patients with Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Selumetinib and Olaparib in Treating Participants with Relapsed or Refractory and Advanced Endometrial, Ovarian, or Other Solid Tumors with RAS Pathway Alterations
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Paclitaxel-Loaded Tumor Penetrating Microparticles for the Treatment of Peritoneal Carcinomatosis
Status: Temporarily Closed to Accrual
Location: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov
IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov
Olaparib in Treating Patients with Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer before Surgery
Status: Temporarily Closed to Accrual
Location: 2 locations
Adavosertib before Surgery in Treating Patients with Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Temporarily Closed to Accrual
Location: 7 locations
Distance-Based Exercise to Preserve Function and Prevent Disability (DEFEND)
Status: Active
Location: 14 locations
Exercise and Lifestyle for Women with Ovarian Cancer and Endometrial Cancer, TEAL Study
Status: Active
Location: 10 locations
A Telehealth Psychosocial Intervention (REVITALIZE) to Reduce Fatigue Interference among Patients with Advanced Ovarian Cancer on PARP Inhibitors
Status: Active
Location: 7 locations
Integrative Medicine for the Improvement of Patient-Reported Outcomes, Values, and Experience
Status: Active
Location: 7 locations
Cryocompression with or without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients with Gynecological Cancers
Status: Active
Location: 4 locations
Survivorship Care Planning (POSTcare-O) to Support Ovarian Cancer Survivors Transitioning to Survivorship Care
Status: Active
Location: 3 locations
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
Status: Active
Location: 3 locations
Psilocybin-Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed with Early-Stage Breast Cancer and Advanced Ovarian Cancer in Remission
Status: Active
Location: 2 locations
Tart Cherry Juice for the Prevention of Peripheral Neuropathy in Patients Receiving Paclitaxel for Stage I-IV Invasive Breast or Ovarian Cancer
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
Prehabilitation Program for Elderly Patients with Stage III-IV Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma, Pancreatic Cancer, Muscle Invasive Bladder Cancer, and Esophageal Cancer Undergoing Neoadjuvant Chemotherapy
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Exercise for the Prevention of Immobility in Patients with Ovarian or Endometrial Cancers Receiving Chemotherapy after Surgery, the MOBILITY Study
Status: Active
Location: Dana-Farber Cancer Institute, Boston, Massachusetts
Standardized Extract of Cultured Lentinula edodes mycelia for Improving Quality of Life in Patients with Ovarian, Fallopian Tube or Peritoneal Cancer Undergoing Chemotherapy
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
An Educational Video to Improve Genetic Testing Understanding and Uptake in Patients with Ovarian and MMRd Endometrial Cancer
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina